Login / Signup

Perspectives on New Vaccines against Arboviruses Using Insect-Specific Viruses as Platforms.

Valéria Lima CarvalhoMaureen T Long
Published in: Vaccines (2021)
Arthropod-borne viruses (arboviruses) are global pathogens circulating endemically with local explosive outbreaks and constant encroachment into new locations. Few vaccines against arboviruses exist; most for humans are in development or clinical trials. Insect-specific viruses (ISVs) offer a unique platform for expression of arbovirus proteins, through the creation of ISV/arbovirus chimeras. Studies have shown promising results of these vaccines with several advantages over their wild-type counterparts. In this review, we discuss the current status of these potential vaccines using ISVs.
Keyphrases
  • aedes aegypti
  • clinical trial
  • wild type
  • current status
  • poor prognosis
  • zika virus
  • high throughput
  • binding protein
  • genetic diversity